This case report describes an outer retinal abnormality associated with taking a RET inhibitor during a clinical trial in a 52-year-old patient with right lung adenocarcinoma and a RET gene fusion. … [Read more...] about Fovea-Involved Outer Retinal Abnormality Induced by a Novel RET Inhibitor
News
Risk Factors for Retinopathy in Young Adults With Type 1 Diabetes
This cohort study investigates whether risk factors other than glucose control are associated with the development of diabetic retinopathy. … [Read more...] about Risk Factors for Retinopathy in Young Adults With Type 1 Diabetes
Novel In-Office Procedure for Retinal Detachment
In this issue of JAMA Ophthalmology, Muni and colleagues report on a novel in-office procedure for the repair of acute rhegmatogenous retinal detachments (RRDs), which involves the injection of a viscoelastic agent into the suprachoroidal space to achieve an internal buckling effect. The authors named the procedure suprachoroidal viscopexy (SCVEXY). The authors had previously … [Read more...] about Novel In-Office Procedure for Retinal Detachment
Progressive Eyelid Lesions in a Woman With Essential Thrombocythemia
A 75-year-old woman with a history of essential thrombocythemia presented with 3 months of progressively enlarging right upper eyelid lesions. Examination revealed a thickened eyelid margin, madarosis, and erythema with some tenderness to palpation but an otherwise normal ocular examination. What would you do next? … [Read more...] about Progressive Eyelid Lesions in a Woman With Essential Thrombocythemia
Bausch + Lomb acquires Elios Vision
December 11, 2024 1 min read Bausch + Lomb acquired Elios Vision, including its technology to perform a minimally invasive glaucoma surgery procedure with an excimer laser, according to a press release. “Our acquisition of Elios Vision demonstrates our ongoing commitment to the rapidly growing number of patients affected by glaucoma,” Anthony Wallace, vice president and … [Read more...] about Bausch + Lomb acquires Elios Vision
VIDEO: Surgeon touts benefits of VisuMax 800 femtosecond laser
December 11, 2024 1 min watch CHICAGO — In this Healio Video Perspective from the AAO meeting, John F. Doane, MD, FACS, of Discover Vision Centers discusses the benefits that the VisuMax 800 femtosecond laser offers patients, surgeons and staff. According to Doane, the VisuMax 800 (Carl Zeiss Meditec) is specifically beneficial for … [Read more...] about VIDEO: Surgeon touts benefits of VisuMax 800 femtosecond laser
Updates on EXG102 and EXG202 for wet AMD from Exegenesis Bio
Exegenesis Bio provided an update on the company’s treatment candidates for wet age-related macular degeneration (wet AMD).EXG102 is an investigational gene therapy for wet AMD that is administered by subretinal injection. EXG202, a next generation version, incorporates the same genetic cargo as EXG102, but is delivered to deep retinal cells by a highly-specific ocular capsid … [Read more...] about Updates on EXG102 and EXG202 for wet AMD from Exegenesis Bio
Study: Fluoxetine improves visual acuity in adults with amblyopia
Iranian researchers led by first author Arash Mirmohammadsadeghi, MD, reported that treating adults with amblyopia with fluoxetine resulted in increased visual acuity (VA) in the amblyopic eyes that was significant compared with control eyes.1 He and his colleagues are from the Eye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran.They … [Read more...] about Study: Fluoxetine improves visual acuity in adults with amblyopia
VIDEO: SLT may yield slower visual field progression vs. eye drops
December 11, 2024 3 min read CHICAGO — In this Healio Video Perspective from the AAO meeting, Victoria L. Tseng, MD, PhD, of the Stein Eye Institute and Doheny Eye Center at UCLA, overviews glaucoma research from a session she moderated. Follow-up data from the LiGHT trial found that patients who underwent selective laser trabeculoplasty may … [Read more...] about VIDEO: SLT may yield slower visual field progression vs. eye drops
Bausch + Lomb acquires ELIOS system, expanding glaucoma treatment options
Bausch + Lomb Corp. today announced that an affiliate has acquired Elios Vision Inc., developer of the ELIOS procedure, the first clinically validated, minimally invasive glaucoma surgery (MIGS) procedure using an excimer laser.According to Bausch + Lomb, the acquisition opens up new opportunities for treating glaucoma effectively without the need for implants, enhancing the … [Read more...] about Bausch + Lomb acquires ELIOS system, expanding glaucoma treatment options